Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hollis

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Molecular Therapy. Methods & Clinical Development|June 2, 2015
The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cellsZulema Romero, Beatriz Campo-Fernandez, Jennifer Wherley, et al.
Human Gene Therapy|August 28, 2013
Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapySatiro Nakamura De Oliveira, Christine Ryan, Francesca Giannoni, et al.
Molecular Therapy. Methods & Clinical Development|May 20, 2020
Creating New β-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer SequencesRichard A Morgan, Feiyang Ma, Mildred J Unti, et al.
Cytotherapy|July 23, 2017
Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell diseaseFabrizia Urbinati, Jennifer Wherley, Sabine Geiger, et al.
Stem Cells (Dayton, Ohio)|March 29, 2014
Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signalingWilliam S Kim, Yuhua Zhu, Qiming Deng, et al.
Stem Cells (Dayton, Ohio)|October 30, 2018
Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA RepairAnastasia Lomova, Danielle N Clark, Beatriz Campo-Fernandez, et al.
Frontiers in Genome Editing|October 29, 2021
Global and Local Manipulation of DNA Repair Mechanisms to Alter Site-Specific Gene Editing Outcomes in Hematopoietic Stem CellsElizabeth K Benitez, Anastasia Lomova Kaufman, Lilibeth Cervantes, et al.
Molecular Therapy. Methods & Clinical Development|September 23, 2024
Lentiviral vectors for precise expression to treat X-linked lymphoproliferative diseasePaul G Ayoub, Julia Gensheimer, Lindsay Lathrop, et al.
Translational Biomedicine|February 10, 2012
Elevated DISC1 transcript levels in PBMCs during acute psychosis in patients with schizophreniaAnn Olincy, Robert House, Bifeng Gao, et al.
Cell Reports|May 31, 2018
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM SyndromeCaroline Y Kuo, Joseph D Long, Beatriz Campo-Fernandez, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Molecular Therapy. Methods & Clinical Development|June 2, 2015
The human ankyrin 1 promoter insulator sustains gene expression in a β-globin lentiviral vector in hematopoietic stem cellsZulema Romero, Beatriz Campo-Fernandez, Jennifer Wherley, et al.
Human Gene Therapy|August 28, 2013
Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapySatiro Nakamura De Oliveira, Christine Ryan, Francesca Giannoni, et al.
Molecular Therapy. Methods & Clinical Development|May 20, 2020
Creating New β-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer SequencesRichard A Morgan, Feiyang Ma, Mildred J Unti, et al.
Cytotherapy|July 23, 2017
Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell diseaseFabrizia Urbinati, Jennifer Wherley, Sabine Geiger, et al.
Stem Cells (Dayton, Ohio)|March 29, 2014
Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signalingWilliam S Kim, Yuhua Zhu, Qiming Deng, et al.
Stem Cells (Dayton, Ohio)|October 30, 2018
Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA RepairAnastasia Lomova, Danielle N Clark, Beatriz Campo-Fernandez, et al.
Frontiers in Genome Editing|October 29, 2021
Global and Local Manipulation of DNA Repair Mechanisms to Alter Site-Specific Gene Editing Outcomes in Hematopoietic Stem CellsElizabeth K Benitez, Anastasia Lomova Kaufman, Lilibeth Cervantes, et al.
Molecular Therapy. Methods & Clinical Development|September 23, 2024
Lentiviral vectors for precise expression to treat X-linked lymphoproliferative diseasePaul G Ayoub, Julia Gensheimer, Lindsay Lathrop, et al.
Translational Biomedicine|February 10, 2012
Elevated DISC1 transcript levels in PBMCs during acute psychosis in patients with schizophreniaAnn Olincy, Robert House, Bifeng Gao, et al.
Cell Reports|May 31, 2018
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM SyndromeCaroline Y Kuo, Joseph D Long, Beatriz Campo-Fernandez, et al.
Pageof 11